About Verogen
Verogen is a Healthcare company based in San Diego (United States) founded in 2017, and was acquired by Qiagen in January 2023. A DNA sequencing platform for forensic science applications is developed. Verogen has completed 1 acquisition, including GEDmatch. Verogen offers products and services including ForenSeq DNA Signature Prep Kit, MiSeq FGx Sequencing System, Universal Analysis Software, and ForenSeq MainstAY Product Line. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Instrument Systems. Its legal entity is VEROGEN, INC. Its competitors include PacBio, Quanterix and Omniome; 3 of its 3 listed competitors have raised funding.
Company details
Verogen is developing a DNA sequencing platform for forensic science. Its flagship product, MiSeq FGx Forensic Genomics System analyzes forensically relevant markers (STRs and SNPs) in a single interrogation. It has got FBI Approval for use by forensic laboratories generating DNA profiles for upload to the National DNA Index System (NDIS).
Products & Services of Verogen
Verogen offers a comprehensive portfolio of products and services, including ForenSeq DNA Signature Prep Kit, MiSeq FGx Sequencing System, Universal Analysis Software, and ForenSeq MainstAY Product Line.
Kit for preparing DNA libraries for forensic sequencing.
System for forensic DNA sequencing and analysis.
Software for managing and interpreting NGS data.
Line of products for advanced forensic DNA applications.
Apps and channels of Verogen
its YouTube channel Verogen has 49 subscribers and 1 videos.
Videos from Verogen
The most watched videos on Verogen's YouTube channel, Verogen (49 subscribers). Click a video to play it here.
More on Verogen.
Investors in Verogen
Verogen has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Qiagen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Products and reagents for molecular diagnostic assays are supplied. | 1984 | qiagen.com | Hilden, Germany |
Investor details for Verogen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Verogen
2 people are tracked at Verogen (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Brett Williams | CEO | Leadership |
Bonnie Clemons | Sales, Service, And Support Process Development & Crm/erp Consultant | Team |
Complete people profiles for Verogen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Verogen
Verogen has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include GEDmatch.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
DNA-based health risk assessment platform | gedmatch.com | San Diego, United States | 2010 | Dec 2019 | •••• |
Complete acquisition details for Verogen
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Competitors of Verogen
Verogen has 3 listed competitors in our database, 3 of them funded. They include PacBio, Quanterix and Omniome.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pacb.com | 2004 | Menlo Park, United States | $395M | 649 | Instrument systems and software for single-molecule real-time sequencing are developed. | |
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. |
Detailed competitors of Verogen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Verogen
The website of Verogen (verogen.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▼ 4.1% vs previous month
Websites whose visitors overlap most with Verogen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| terragene.com | 100% | 24.4K | #1,157,387 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Verogen (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Verogen
Complete news archive for Verogen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Verogen
Verogen was founded in 2017.
Verogen is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Verogen is developing a DNA sequencing platform for forensic science. Its flagship product, MiSeq FGx Forensic Genomics System analyzes forensically relevant markers (STRs and SNPs) in a single interrogation. It has got FBI Approval for use by forensic laboratories generating DNA profiles for upload to the National DNA Index System (NDIS).
Verogen offers ForenSeq DNA Signature Prep Kit, MiSeq FGx Sequencing System, Universal Analysis Software, and ForenSeq MainstAY Product Line.
Verogen has made 1 acquisition, including GEDmatch.
Verogen has 1 investor. Key investors include Qiagen.
Verogen operates through Verogen, Inc..
Yes. Verogen was acquired by Qiagen in January 2023.